OTCMKTS:CANSF Willow Biosciences (CANSF) Stock Price, News & Analysis $0.09 0.00 (0.00%) As of 07/21/2026 02:58 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Willow Biosciences Stock (OTCMKTS:CANSF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Willow Biosciences alerts:Sign Up Key Stats Today's Range$0.09▼$0.0950-Day Range$0.09▼$0.1352-Week Range$0.05▼$0.15Volume100 shsAverage Volume6,665 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Willow Biosciences Inc. is a Canadian biotechnology company that develops and manufactures specialty cannabinoids through fermentation-based production. Leveraging a proprietary yeast platform, the company engineers strains to produce high‐purity rare cannabinoids such as cannabigerol (CBG), cannabidiol (CBD) and other minor cannabinoids. This approach offers a scalable, consistent and sustainable alternative to traditional plant extraction methods, addressing supply chain challenges and quality variability associated with botanical sources. The company operates a demonstration‐scale biomanufacturing facility in Calgary, Alberta, where it optimizes fermentation processes, downstream extraction and purification protocols. Willow Biosciences collaborates with contract development and manufacturing organizations (CDMOs) and academic partners to advance process development and analytical capabilities. Its products target pharmaceutical, nutraceutical, cosmetic and research markets, supplying active pharmaceutical ingredient (API)‐grade cannabinoids for drug development, clinical trials and consumer product formulations. Founded in 2015 by alumni of the University of Calgary’s Synthetic Biology Centre, Willow Biosciences went public on the Canadian Securities Exchange under the ticker “WBIO” and trades in the U.S. over‐the‐counter market as CANSF. The company is led by President and Chief Executive Officer Kam Daya, whose team brings expertise in bioprocess engineering, regulatory affairs and life‐science commercialization. Willow Biosciences continues to expand its product pipeline and scale its manufacturing capacity to meet growing global demand for high‐purity cannabinoid ingredients.AI Generated. May Contain Errors. Read More Receive CANSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Willow Biosciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CANSF Stock News HeadlinesAtlas Energy Corp. Announces Appointments to Subsidiary Board and Extension of TSXV Sandbox Exit DeadlineJune 22, 2026 | globenewswire.comAtlas Energy Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Operations and Filing of Its 2025 AIFApril 6, 2026 | globenewswire.comElon says “don’t save money.” Is he right?Robert Kiyosaki, author of Rich Dad Poor Dad, says you don't have to wait for Elon Musk's vision of universal basic income. His Patriot Income Plan - funded by 14 partnerships controlling America's critical oil and gas infrastructure - already pays 10% a year with 42 payouts annually. Some investors are already collecting $4,800 a month. One has built income up to $25,000 a month. These partnerships have averaged 20% annual gains since 2020, with no U.S. tax dollars involved. The next payout drops in days.July 22 at 1:00 AM | Freedom Financial (Ad)Atlas Energy Corp. Expands Deal Pipeline Amid Favorable Market ConditionsNovember 14, 2025 | tipranks.comAtlas Energy Corp. Completes Transformative RecapitalizationJune 19, 2025 | tipranks.comWillow Biosciences Inc. Receives Conditional TSXV Listing ApprovalJune 16, 2025 | tipranks.comWillow Biosciences to Transform into Atlas Energy Corp. with New Strategic FocusMay 12, 2025 | tipranks.comWILLOW BIOSCIENCES REPORTS FIRST QUARTER 2025 FINANCIAL RESULTSMay 12, 2025 | prnewswire.comSee More Headlines CANSF Stock Analysis - Frequently Asked Questions How have CANSF shares performed this year? Willow Biosciences' stock was trading at $0.1234 at the beginning of 2026. Since then, CANSF stock has decreased by 29.7% and is now trading at $0.0867. How do I buy shares of Willow Biosciences? Shares of CANSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today7/22/2026Next Earnings (Estimated)8/17/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:CANSF CIKN/A Webwww.willowbio.com Phone(403) 910-5140FaxN/AEmployees19Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (OTCMKTS:CANSF) was last updated on 7/22/2026 by MarketBeat.com Staff. From Our PartnersAmerica’s answer to universal basic incomeRobert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...Freedom Financial | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredTSM just handed Trump's secretive AI project $100 billionTaiwan Semiconductor just committed another $100 billion to U.S. chip manufacturing - on top of $165 billion a...InvestorPlace | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredElon is about to dominate the biggest arms race in tech historyMicrosoft, Amazon, Alphabet, and Meta have collectively poured nearly $700 billion into AI infrastructure in 2...The Oxford Club | SponsoredWall Street legend put 60% in one stock — here’s the tickerOne of America's most famous investors put 60% of his fund into a single stock - and Whitney Tilson of Stansbe...Stansberry Research | SponsoredIt all happens tonight.Tonight, trader Sean Allison is hosting a live session to walk through his Zero-Dollar Trade Advantage strateg...Trade Thirsty | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Willow Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Willow Biosciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
